Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca 2+ Homeostasis and Hepatic Insulin Signaling
Diabetes & Metabolism Journal · 04.11.2026
DOI: 10.4093/dmj.2026.0022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, online erschienen am 04.11.2026. Verfasst von Bayaraa Amgalan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Science and Technology, Gachon Advanced Institute for Health Science and Technology, Gachon University, Incheon, Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Science and Technology, Gachon Advanced Institute for Health Science and Technology, Gachon University, Incheon, Korea.
- Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon, Korea.
- Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon, Korea. ohkim323@gmail.com.
- Department of Health Science and Technology, Gachon Advanced Institute for Health Science and Technology, Gachon University, Incheon, Korea. bcoh@gachon.ac.kr.
- Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon, Korea. bcoh@gachon.ac.kr.
Zitieren
APA
Amgalan, B., Noh, S. W., Ryu, H. S., Kim, Y. J., Ahn, H. J., Kim, O. H., & Oh, B. C. (2026). Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca 2+ Homeostasis and Hepatic Insulin Signaling. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2026.0022
Vancouver
Amgalan B, Noh SW, Ryu HS, Kim YJ, Ahn HJ, Kim OH, et al. Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca 2+ Homeostasis and Hepatic Insulin Signaling. Diabetes & Metabolism Journal. 2026. doi:10.4093/dmj.2026.0022
BibTeX
@article{Amgalan2026,
author = {Amgalan, Bayaraa and Noh, Seung Wan and Ryu, Han Sol and Kim, Yeon-Ju and Ahn, Hyun-Jung and Kim, Ok-Hee and Oh, Byung-Chul},
title = {Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca 2+ Homeostasis and Hepatic Insulin Signaling},
journal = {Diabetes & Metabolism Journal},
year = {2026},
doi = {10.4093/dmj.2026.0022}
}
EUVIMED